P

Inventor

BALOG JAMES AARON

US57 patents
⚠️ This page may combine multiple inventors who share the name “BALOG JAMES AARON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRISTOL MYERS SQUIBB CO

41 patents
US7141578B2Nov 28, 2006

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO17 citations92
US9790169B2Oct 17, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO19 citations91
US7001911B2Feb 21, 2006

Fused cyclic modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO31 citations91
US11066383B2Jul 20, 2021

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO3 citations73
US10696648B2Jun 30, 2020

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO3 citations73
US10689331B2Jun 23, 2020

IDO inhibitors

BRISTOL MYERS SQUIBB CO2 citations73
US10633342B2Apr 28, 2020

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO2 citations73
US9895330B2Feb 20, 2018

IDO inhibitors

BRISTOL MYERS SQUIBB CO2 citations73
US9675571B2Jun 13, 2017

Inhibitors of indoleamine 2,3-dioxygenase (IDO)

BRISTOL MYERS SQUIBB CO6 citations73
US9624188B2Apr 18, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO3 citations73
US7087636B2Aug 8, 2006

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO9 citations73
US10959986B2Mar 30, 2021

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO3 citations72
US10399933B2Sep 3, 2019

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

BRISTOL MYERS SQUIBB CO3 citations72
US9758492B2Sep 12, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO4 citations72
US10399932B2Sep 3, 2019

Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer

BRISTOL MYERS SQUIBB CO3 citations71
US10167254B2Jan 1, 2019

IDO inhibitors

BRISTOL MYERS SQUIBB CO1 citations71
US9765018B2Sep 19, 2017

IDO inhibitors

BRISTOL MYERS SQUIBB CO4 citations71
US8969586B2Mar 3, 2015

Substituted bicyclic heteroaryl compounds

BRISTOL MYERS SQUIBB CO2 citations63
US7776859B2Aug 17, 2010

Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function

BRISTOL MYERS SQUIBB CO2 citations63
US7235563B2Jun 26, 2007

Spirocyclic compounds useful as modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO3 citations63
US11649212B2May 16, 2023

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations62
US11351164B2Jun 7, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations62
US11337970B2May 24, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations62
US10544099B2Jan 28, 2020

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations62
US9133139B2Sep 15, 2015

Fluoroalkyl-1,4-benzodiazepinone compounds

BRISTOL MYERS SQUIBB CO2 citations62
US7550458B2Jun 23, 2009

Tricycloundecane compounds useful as modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO2 citations62
US7517904B2Apr 14, 2009

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO1 citations62
US12145927B2Nov 19, 2024

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US11548870B2Jan 10, 2023

Compounds useful as inhibitors of helios protein

BRISTOL MYERS SQUIBB CO1 citations61
US11447449B2Sep 20, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US11253525B2Feb 22, 2022

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO1 citations61
US7432267B2Oct 7, 2008

Fused cyclic modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO2 citations61
US7655688B2Feb 2, 2010

Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO5 citations60
US12331045B2Jun 17, 2025

Substituted phenyl oxazolone compounds

BRISTOL MYERS SQUIBB CO0 citations58
US11718601B2Aug 8, 2023

Pyridinyl substituted oxoisoindoline compounds

BRISTOL MYERS SQUIBB CO0 citations56
US12291522B2May 6, 2025

Galectin-3 inhibitors

BRISTOL MYERS SQUIBB CO0 citations52
US11066392B2Jul 20, 2021

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO0 citations52
US9598436B2Mar 21, 2017

Substituted bicyclic heteroaryl compounds

BRISTOL MYERS SQUIBB CO0 citations52
US7342034B2Mar 11, 2008

Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO0 citations52
US12059420B2Aug 13, 2024

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

BRISTOL MYERS SQUIBB CO0 citations51
US7655689B2Feb 2, 2010

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

BRISTOL MYERS SQUIBB CO1 citations51

FLEXUS BIOSCIENCES INC

7 patents

VELAPARTHI UPENDER

1 patent

AUSTIN JOEL FRANCIS

1 patent

Showing the top 50 of 57 patents by PatentIndex Score.